| Authors: |
El Bouzidi K; Division of Infection & Immunity, University College London, London, United Kingdom.; Institute for Global Health, University College London, London, United Kingdom., Murtala-Ibrahim F; Institute of Human Virology Nigeria, Abuja, Nigeria., Kwaghe V; University of Abuja Teaching Hospital, Abuja, Nigeria., Datir RP; Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, United Kingdom., Ogbanufe O; U.S. Centers for Disease Control and Prevention, U.S. Embassy, Abuja, Nigeria., Crowell TA; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD., Charurat M; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD., Dakum P; Institute of Human Virology Nigeria, Abuja, Nigeria., Gupta RK; Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, United Kingdom.; Africa Health Research Institute, Durban, South Africa; and., Ndembi N; Institute of Human Virology Nigeria, Abuja, Nigeria.; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD.; Africa Centres for Disease Control and Prevention, African Union Commission, Addis Ababa, Ethiopia., Sabin CA; Institute for Global Health, University College London, London, United Kingdom. |
